chrisvoncsefalvay/vaers-outcomes huggingface dataset:
little dizzy/ lightheaded; body aches; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little dizzy/ lightheaded), MYALGIA (body aches), CHILLS (chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced DIZZINESS (little dizzy/ lightheaded), MYALGIA (body aches), CHILLS (chills) and PYREXIA (fever). At the time of the report, DIZZINESS (little dizzy/ lightheaded), MYALGIA (body aches), CHILLS (chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Nausea/vomiting/chills 9/25/13, refractory vomiting. Fever 102 degrees 9/25/13. Pt presented to urgent care and was admitted to ICU by Dr.
Body aches occurred during night of 4/7. Body aches continued 4/8 and fever of 100.1 during evening of 4/8. Friday 4/9 feel normal.
Pt came back to pharmacy 4/8/16 about 2p complaining of injection site redness and swelling. Both pharmacists looked at the site on the right arm and told patient to keep watch if it spreads that it did not seem serious. After patient left, pharmacists said based on injection site reaction it was possible that it might have been received intramuscularly. RPh called Merck and Merck also took information down and Merck's medical team said she would fax study showing that patient would still be able to mount a response and ADR were the same as SQ.
injection site pain, redness, and swelling; injection site pain, redness, and swelling; injection site pain, redness, and swelling; headache; chills; muscle and joint pain; muscle and joint pain; nausea; dizziness; weakness; This is a spontaneous report from a contactable consumer (the patient). A 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EM9809), via an unspecified route of administration in the left arm on 06Feb2021 13:30 (at the age of 66-years-old) as a single dose for COVID-19 immunization. The patient's medical history included slightly elevated blood pressure, not taking medication, and COVID prior to vaccination, on an unspecified date. The patient had no known allergies. The patient was not pregnant at the time of vaccination. Concomitant medications included paracetamol (TYLENOL) and vitamin supplements. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Feb2021 16:00, the patient experienced injection site pain, redness, and swelling; headache, chills, muscle and joint pain, nausea, dizziness and weakness. No treatment was received for the events. The clinical outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
This is a spontaneous report from a contactable pharmacist. An 87-year-old female patient received PREVNAR 13 (exp date May2016, NDC 0005 1971 05), intramuscular in right deltoid, on 13Jan2015, at 0.5 ml single. Relevant medical history and concomitant medications were not reported. On 14Jan2015 the patient experienced rash on hands and face, but no redness at the injection site. The patient went to her doctor on 19Jan2015 because of the rash and received a steroid shot. Outcome of the event was not recovered. Follow-up (27Feb2015): Follow-up attempts completed. No further information expected.
Hives, redness, heat at site. Hives appeared 2 days after injection of vaccine.
Information has been received from a physician concerning a 16 year old female patient who on 19-SEP-2005 was vaccinated with the first dose of MMR II. On 15-JUL-2008, the patient received the second dose of MMR II. It was reported that on 08-NOV-2009, the patient experienced mumps. On 09-NOV-2009, the patient was diagnosed with left parotitis and afebrile. The first blood work was performed on 09-NOV-2009 and the results were IgM: 1:10:00, IgG: 4.61 and serum amylase: 311. At the time of the report the outcome of the patient was not reported. Additional information has benn requested.
Pfizer Covid vaccine treatment under Emergency Use Authorization(EUA):After receiving second Covid Vaccine, 2 days later patient reported fever, headache, muscle aches, diarrhea, nausea and breast on injection side painful, sore throat, right ear ache and exhaustion. Rapid Covid test which was negative . On 1/28/2021 patient continued to report her legs were still very painful with a headache and exhaustion
Woke up this morning with headache, dizziness, coughing, palpitation, slight nausea, low grade temperature.
pt recv vax&was 2wks pregnant @ the time;FEB96 pt devel abruptio placentae&the conceptus was lost;
patient received wrong dosage for moderna vaccine series, pt received 10mg and should've received 25mg. Pt had no known reactions, pt monitored for 15 minutes.
as described on other page...high fever..unable to move or eat...large painful lump in leg where shot was given..moaning in sleep
Chest discomfort; fever; chills; body ache; This spontaneous case was reported by a physician and describes the occurrence of CHEST DISCOMFORT (Chest discomfort), PYREXIA (fever), CHILLS (chills) and MYALGIA (body ache) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (Chest discomfort), PYREXIA (fever), CHILLS (chills) and MYALGIA (body ache). At the time of the report, CHEST DISCOMFORT (Chest discomfort), PYREXIA (fever), CHILLS (chills) and MYALGIA (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
After shot, extreme fatigue and dizziness for 24 hours and sore arm.   After the 2nd shot I experienced a slight headache for 1 week.  On April 4, I experienced an occullar migraine for about 30 minutes.
approx 14 days p/recv vax pt devel diarrhea characterized by dark, soft stools;
He says that overnight after the vaccine his left ear now feels plugged and as a result he cannot hear well.  He noticed it starting the morning after the vaccination and is still experiencing the same sensation 3 days later.  It still feels plugged.
After last chemo infusion on 11/28/2022, it was questioned whether I should get my booster in January  2023 before I started radiation therapy. After receiving booster for the next 4 days I became very ill with all the side effects I experienced with chemotherapy. Bone and muscle pain, nausea, vomiting, bloated,gas,very tired and neuropathy. All these symptoms were much better before the booster but became very severe the day after the booster. It was debilitating.
This spontaneous report as received from a consumer (mother of patient) refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL in the arm. Other suspect therapies included AFLURIA. Dose, lot and expiry date were unknown. The vaccines were administered on same day in the same arm and the patient had developed swelling at injection site on that day. The outcome of swelling at injection site is unknown. Additional information has been requested.
Quick, heavy heartbeat for the day. Shortness of breath for one day. Intense chest pain for one day. Chest tightness for one day. I am on vaccine day three.
My blood sugar began spiking within 24 hours of the injection.  My blood sugar is normally well under control and nothing changed in my eating or exercise habits whatsoever.  Blood sugar shot up by 60+ points and has NEVER been this high- it reached 172.  My average blood sugar over a 30 day period was 112.  My blood sugar has been all over the place since the injection.  Lows as low as 52 and highs to 182.  Again, the only variable is the injection.  Something is wrong.  Called the pharmacist and she had not heard of this occurring and encouraged me to report it.  It's been exactly one week since the injection and the blood sugar is still out of control.
Significant and debilitating menstrual pain in August. Never had menstrual pain previously.  Cycles after August have included irregular flow, abnormal color, and unusual length.
R Deltoid 4mmx3mm Red and Swollen, Warm to the touch
pain redness at the injection site, headache, muscle pain, fever, and upset stomach starting in the afternoon after injection on 9/30/2020. Mother treated at home with alternating tylenol and ibuprofen. Keflex 500 mg tablet started at office visit on 10/2/2020.
A medication error was made. Pt was given 0.2ml dose of undiluted vaccine. Pt did not present with any adverse signs and symtoms during observation period following injection. Call placed to parent of pt, message was left checking on pt and with request for call back to clinic.  No known adverse symptoms at this time.
I awoke at 1 am with hot and cold flashes, on-and-off fever reaching 101.0F, body aches, and headache, with a severity lasting 24 hours, then within the 24-36+ hour period afterwards I experienced milder symptoms of sleeplessness, nausea, heart arrhythmia and faintness possibly caused by dehydration, diarrhea, loss of appetite, flushed face, and continued headache.
pain in my upper arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (pain in my upper arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (pain in my upper arm). At the time of the report, MYALGIA (pain in my upper arm) outcome was unknown.            No concomitant medications was reported. No treatment drug details was reported.
The vision became distorted, body aches, headache, the roof of my mouth became very sore, nausea, and fatigue.
Chills, diarrhea, malaise, joint (knee) pain over next 48 hrs. Arm swollen, red, hot, painful.
"I" have ringing in "my" ears; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 11:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, obesity and post COVID-19 diagnosed on 28Mar2020. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol / desogestrel (ISIBLOOM), omeprazole (PRILOSEC), fluticasone propionate / salmeterol xinafoate (ADVAIR), montelukast sodium (SINGULAIR) and cetirizine hydrochloride (ZYRTEC); all for unknown indications from an unknown date and unknown if ongoing. On 12Mar2021 at 17:45 (also reported as 05:45), 18 hours post vaccination the patient experienced ringing in her ears. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event she had ringing in her ears was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
The day after  the booster shot, my juvenile rheumatoid arthritis came back and could not walk, 3 weeks later i am still having issues.
Pt recvd Pneumococcal vax 18NOV91 & on 20NOV91 pt devel runny nose, achiness & fever (temp not checked but felt warm); denies local rxn on the inject site; pt has not taken any type of analgesics since sx occurred;
Pain, redness and swelling within 3-4 hours, post vax. Later in the day on 3/8/01 had diarrhea and swelling of finger on left hand. On 3/9/01, had rash and pruritus at injection area and during the day it developed in a generalized body rash with itching. On 3/10/01, the rash and pruritus diminished. Treatment: put heat at injection site on 3/8/01 and 3/9/01. Called her doctor and he ordered Tylenol and rest.
Mother stated 24 hours after vaccine, swelling of top lip, one eye, one hand and both feet. Was taken to ER and transported by ambulance to another hospital. Was admitted to hospital 9/12/03 and released 9/14/03. Mother states no known allergies; states he had three red spots on neck. Medical records state decreased PO intake. msv
"Ache" "sore" pain upper right arm upon movement over head or lifting". Onset after vaccine administered on 10/10/13 per patient. Patient says Tylenol and heat has helped some. Pain continues to this date. Patient says pain still "off/on" since Oct 2013.
Tested positive; Tested positive; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group.  A male patient received bnt162b2 omi xbb.1.5 (BNT162B2 OMI XBB.1.5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The reporter stated that her husband got a Pfizer covid-19 vaccine shot however he tested positive. Outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
erythema or redness at injection site and surrounding area lasting over 7 days. rash has irregular edges and may be a reaction to injection site barrier bandage.
Employee reports noticing S/S (pain, redness, swelling and tenderness) on the 10/28/21. Donor refuse medical care at work and denies receiving any outside care. Employee was recommended to apply cold compresses to area and to seek medical care if symptoms worsen.
Erythema about size of silver dollar. Not swollen. Benadryl and ice packs.
he was showing reaction, chest pain and severe chest pain; This is a spontaneous report from a contactable consumer reporting on behalf of the son. A 21 years old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 03Jun2021, as second single dose, for COVID-19 immunization. The first dose of BNT162B2 was given on an unknown date. Medical history and concomitant medications were not reported. The patient took the second vaccine dose and he was showing reaction, chest pain and severe chest pain since an unspecified date in Jun2021. The reporter took him to ER because he was showing severe chest pain and he was 21 years old. Reporter seriousness for the event was unspecified. Event outcome was unknown.  Information on the lot/batch number has been requested.
Narrative:  Patient is a 54 year old MALE with diabetes with hx of CAD s/p 3v CABG age 41, stent x 1 in 2015 and bilateral carotid artery stenosis. Relevant PMH: Carotid artery stenosis Essential hypertension Hyperlipidemia Coronary artery disease Diabetes mellitus Deep venous thrombosis of lower extremity Died on 12/10/2021 at work (hospital) expectantly. Pt had received a covid vaccine on 8/17/2021. Death is not related to covid vaccine.
COVID symptoms and positive COVID test; COVID symptoms and positive COVID test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2), on 18Nov2021 at 16:00 as dose 1, single (Lot number: 32030BD), in left arm and on 04Jan2022 at 20:00 as dose 2, single (Batch/Lot number: unknown) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: AMLODIPINE, start date: 01Jan2021, stop date: 20May2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovered" (2022) and all described as "COVID symptoms and positive COVID test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: The patient received COVID 19 Treatment with Paxlovid (fy6826) from 03May2022 to 07May2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
she experienced fatigue; she experienced redness on her arm; she experienced muscle pain; she experienced aches; she experienced rash from her shoulders and across her chest; she experienced leg pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of fatigue in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11-OCT-2023, the patient received the 1st dose of Shingrix. On 13-OCT-2023, 2 days after receiving Shingrix, the patient experienced fatigue (Verbatim: she experienced fatigue), erythema of extremities (Verbatim: she experienced redness on her arm), muscle pain (Verbatim: she experienced muscle pain), pain (Verbatim: she experienced aches), rash (Verbatim: she experienced rash from her shoulders and across her chest) and leg pain (Verbatim: she experienced leg pain). The outcome of the fatigue, erythema of extremities, muscle pain, pain, rash and leg pain were not resolved.   It was unknown if the reporter considered the fatigue, erythema of extremities, muscle pain, pain, rash and leg pain to be related to Shingrix.     It was unknown if the company considered the fatigue, erythema of extremities, muscle pain, pain, rash and leg pain to be related to Shingrix.   Additional Information: GSK receipt date: 17-Oct-2023 The patient who received her first dose of Shingrix and 2 days after the dose she experienced fatigue, aches, muscle pain, redness on her arm, rash from her shoulders and across her chest, and leg pain.  Did not consent to follow-up.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concurrent conditions, medical history, or concomitant medications. In October 2013, a pharmacist at a pharmacy administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries/conditions (dose, route, and lot # not provided). In February 2017, the patient was treated by a physician at a medical group for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages.  The outcome of the events was not recovered.  Causality assessment was related. Additional information has been requested.
After 1 dose of DTAP and HIB administered, child pulled away and immunization was administered onto the floor. Fresh doses were drawn by MA and given without problem. The other 3 doses were without incident. Onset of urticaria, 10 days, post vax, lasting 3 weeks to date. Hives are ongoing to date.
3-13-17 0850: 21 yr old, patient presented to the clinic for TD booster. She received a TDaP vaccine in 2006. TD vaccine not available at the time. BOOSTRIX is to be given in place of TD vaccine during shortage. 855: BOOSTRIX vaccine administered into left deltoid muscle. 900: Pt stated, "Is this supposed to be itching like this where you give me that shot?" Lifted patient's sleeve and found 3 in x 4 in erythema area, warm to touch. Pt alert and oriented. No respiratory distress noted no other complaints. 901: Notified nurse. Administered BENADRYL 25 mg PO per protocol at 0905 am. 905: Vitals 104/73, 109, 16, 94%/. Pt sitting up in chair alert and oriented. 915: Pt alert and oriented. Remains sitting up in chair. Denies itching. Erythema area non measuring 2 in x 3 in. No respiratory distress noted. RR 16. 930: Vitals 109/62, 90, 16, 96%. No physical distress noted. Pt states, "It's not itching anymore and not near as red. 3-13-17 0935: Ambulated out of clinic with no physical distress noted. Pt stated, "I will call you as soon as I get home." 955: Received phone call from patient stating, "I've made it home and I feel fine. It's not even red anymore. Thank you for everything!" 1200: Notified staff. 1210: Notified staff. 12:15: Notified nurse.
After the vaccination, I had muscle soreness and lethargy. I attributed it to having both vaccines the same day. On December 24, 2022, I woke up and knew I wasn't feeling well. I tested for COVID-19 at home. The result was positive. I had a telehealth appointment on December 26, 2022. By that time, I was quite sick. I had a headache, nausea, muscle aches, mild congestion, and diarrhea. I started losing my taste. I also had a 102-degree fever. I was prescribed PAXLOVID. My symptoms lasted fully for about two weeks. At one point, it felt like my muscles were burning. After about two weeks, I started getting better gradually. It was about a month before I felt back to normal.
sick; tachycardia; pain; dizziness; chills; fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of ILLNESS (sick), TACHYCARDIA (tachycardia), PAIN (pain), DIZZINESS (dizziness) and CHILLS (chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick), TACHYCARDIA (tachycardia), PAIN (pain), DIZZINESS (dizziness), CHILLS (chills) and PYREXIA (fever). At the time of the report, ILLNESS (sick), TACHYCARDIA (tachycardia), PAIN (pain), DIZZINESS (dizziness), CHILLS (chills) and PYREXIA (fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported   Reporter did not allow further contact
5 days post vax developed fever since 18MAR highest 102(AX); Dx OM;